BRAINSTORM CELL THERAPEUTICS INC. Total Liabilities and Equity
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Total Liabilities and Equity of $788.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-14
- 2026-06-30: Liabilities and Equity $788.00K.
- 2026-03-31: Liabilities and Equity $755.00K.
- 2025-12-31: Liabilities and Equity $1.02M.
- 2025-09-30: Liabilities and Equity $1.38M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $788.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $755.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.02M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $1.38M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.57M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $3.57M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.83M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $2.02M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $5.68M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $3.35M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $4.21M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $5.68M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $5.75M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $7.87M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $8.45M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $13.25M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $18.96M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $25.79M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $29.28M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $34.54M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $42.23M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $48.57M 10-Q · filed 2021-04-26 | |
| 2020-12-31 | $51.26M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $32.69M 10-Q · filed 2020-10-15 | |
| 2020-06-30 | $19.22M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $18.07M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $6.53M 10-K · filed 2021-02-04 | |
| 2019-09-30 | $7.81M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $8.86M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $11.85M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $11.23M 10-K · filed 2020-02-18 | |
| 2018-09-30 | $13.77M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $21.02M 10-Q · filed 2018-07-23 | |
| 2018-03-31 | $9.41M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $11.42M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $11.34M 10-Q · filed 2017-10-17 | |
| 2017-06-30 | $8.00M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $9.03M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $10.77M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $11.72M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $13.15M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $13.81M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $17.08M 10-K · filed 2017-03-29 | |
| 2015-09-30 | $18.36M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $20.36M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $22.39M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $9.91M 10-K · filed 2016-03-09 | |
| 2014-09-30 | $11.40M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $12.52M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $4.19M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $4.73M 10-K · filed 2015-03-26 | |
| 2013-09-30 | $6.21M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $3.79M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $4.75M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $5.14M 10-K · filed 2014-03-27 | $5.31M 10-K · filed 2013-03-14 |
| 2012-09-30 | $5.72M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $1.85M 10-Q/A · filed 2012-08-29 | |
| 2012-03-31 | $2.25M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $2.74M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $3.25M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $3.62M 10-Q/A · filed 2011-09-07 | |
| 2010-12-31 | $1.09M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |